Condition: Diabetes Mellitus · Diabetic Retinopathy (DR) · Sponsor: Orbis
The goal of this clinical trial is to determine whether there is an increase in participant uptake of diabetes mellitus (DM) and diabetic retinopathy (DR) services and improved quality of patient-centered diabetic care resulting from the use of automated voice message reminders to sensitize people with DM about the potential for sight loss alongside the provision of free reading glasses. The main questions it aims to answer are: 1. Will the proportion of patients completing their scheduled DR and DM appointments within 3 weeks of the scheduled date be significantly increased in the group receiving the automated voice messages containing both appointment reminders and messaging about the importance of visit and medication compliance in reducing the risk of vision loss, compared with participant messages which only remind them of their appointments? 2. What is the cost-effectiveness, measured as total intervention cost per additional patient complying with the suggested exam?
This description comes directly from the study's public registry record.
Lutful Husain · +88 01711626852 · lutful.husain@orbis.org
Nathan Congdon · +44 7748751393 · ncongdon1@gmail.com
Always discuss trial participation with your own doctor first.
| Gausul Azam BNSB Eye Hospital | Dinajpur, Bangladesh | Recruiting |
| Dinajpur Diabetes & Swasthoseba Hospital | Dinajpur Sadar, Bangladesh | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06968611